ESC 365 - Doctor Hyojeong Ahn

Speaker illustration

Doctor Hyojeong Ahn

Seoul National University Hospital, Seoul (Korea (Republic of))

Member of:

Presentations Articles

Increased right atrial 18f-FDG uptake in persistent atrial fibrillation: insights across young vs. old age groups

Event: EHRA 2025

Topic: Pathophysiology and Mechanisms

Session: Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias

Clonal hematopoiesis and left atrial remodeling in the young: a UK biobank cardiac MRI study

Event: EHRA 2025

Topic: Genetic Aspects of Arrhythmias

Session: Young Investigator Award Clinical Cardiology

Left atrial fibrosis-guided ablation in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials

Event: ESC Congress 2023

Topic: Rhythm Control, Catheter Ablation

Session: Novel approaches and technologies for catheter ablation of atrial fibrillation

Clonal hematopoiesis of indeterminate potential in atrial fibrillation: prevalence and an association with progression

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Pathophysiology and mechanisms of atrial fibrillation

Accelerometer-derived physical activity and the risk of death, heart failure, and stroke in atrial fibrillation patients: A prospective study from UK Biobank

Event: EHRA 2023

Topic: Lifestyle Modification

Session: Clinical - SCD

Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus

Event: EHRA 2023

Topic: Rhythm Control, Hybrid Therapy

Session: Atrial Fibrillation - Round 1 - Drugs, Prevention

Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis

Event: ESC Congress 2022

Topic: Drug therapy

Session: Individual treatment strategies in atrial fibrillation

Paradoxical association between lipid levels and incident atrial fibrillation according to statin usage

Event: ESC Congress 2022

Topic: Prevalence and Incidence of Atrial Fibrillation

Session: Atrial fibrillation in context of concomitant medical conditions

Impact of metabolic syndrome and its components on the progression of coronary artery calcification in statin-naive young adults: results from the KOICA registry

Event: ESC Congress 2022

Topic: Cardiovascular Risk Assessment

Session: Cardiovascular risk assessment 2

Impact of metabolic syndrome on the risk of ischemic stroke in non-anticoagulated atrial fibrillation patients having low CHA2DS2-VASc scores

Event: ESC Congress 2022

Topic: Stroke in Atrial Fibrillation

Session: Clinical challenges in atrial fibrillation

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources